Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: 1. To compare the safety and efficacy of Hydroxychloroquine with Ribavirin and standard treatment in patients with non-severe COVID-19 infection 2. To compare the safety and efficacy of standard treatment, Lopinavir-ritonavir with Ribavarin, and Hydroxychloroquine with Ribavirin in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Panda, Prasan Kumar, Bandyopadhyay, Arkapal, Singh, Budha Charan, Moirangthem, Bikram, Chikara, Gaurav, Saha, Sarama, Bahurupi, Yogesh Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573526/
https://www.ncbi.nlm.nih.gov/pubmed/33081849
http://dx.doi.org/10.1186/s13063-020-04774-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573526/
https://www.ncbi.nlm.nih.gov/pubmed/33081849
http://dx.doi.org/10.1186/s13063-020-04774-5

Ejemplares similares